To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.

HR 3029, the Nucleic Acid Standards for Biosecurity Act, directs the National Institute of Standards and Technology (NIST) to develop new screening standards for synthetic DNA and RNA production to prevent misuse. It requires NIST to research improved testing accuracy, security protocols for sequence databases, and technical guidance for screening tools, with a stakeholder consortium including industry and researchers to set priorities. The bill authorizes $5 million annually (2026-2030) for NIST to carry out this work and mandates a report to Congress within 18 months of the first consortium meeting. This directly affects biotechnology companies, research institutions, and labs producing synthetic genetic materials by establishing new biosecurity screening requirements.